FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Keating

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Anatomy

Bone Marrow

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
Ohad Benjamini; Zeev Estrov; Preetesh Jain; Ellen Schlette; Jade S Sciffman; Michael Keating
Chronic lymphocytic leukemia with central nervous system involvement: a high-risk disease?
Ravin Garg; Michael Keating; Susan Lerner; Lynne Abruzzo; Alessandra Ferrajoli; Sherry Pierce; William Wierda; Susan O'Brien
The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemia.
Deqin Ma; L Jeffrey Medeiros; Bal M Mishra; Keyur P Patel; Rachel Sargent; William Wierda; Hui Yao; Lynne V Abruzzo; Zhao Chen; Michael Keating; Rajyalakshmi Luthra
Array comparative genomic hybridization analysis identifies recurrent gain of chromosome 2p25.3 involving the ACP1 and MYCN genes in chronic lymphocytic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Keating (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Ohad Benjamini; Zeev Estrov; Preetesh Jain; Ellen Schlette; Jade S Sciffman; Michael Keating
Chronic lymphocytic leukemia with central nervous system involvement: a high-risk disease?
Clinical lymphoma, myeloma & leukemia 2013;13(3):338-41.
2012: Ravin Garg; Michael Keating; Susan Lerner; Lynne Abruzzo; Alessandra Ferrajoli; Sherry Pierce; William Wierda; Susan O'Brien
The prognostic difference of monoallelic versus biallelic deletion of 13q in chronic lymphocytic leukemia.
Cancer 2012;118(14):3531-7.
2011: Deqin Ma; L Jeffrey Medeiros; Bal M Mishra; Keyur P Patel; Rachel Sargent; William Wierda; Hui Yao; Lynne V Abruzzo; Zhao Chen; Michael Keating; Rajyalakshmi Luthra
Array comparative genomic hybridization analysis identifies recurrent gain of chromosome 2p25.3 involving the ACP1 and MYCN genes in chronic lymphocytic leukemia.
Clinical lymphoma, myeloma & leukemia 2011;11 Suppl 1():S17-24.
2010: Andrew Lamb; Farhad Ravandi; Susan O'Brien; Jorge Cortes; Stefan Faderl; Guillermo Garcia-Manero; Elias Jabbour; William G Wierda; Tapan Kadia; Sherry Pierce; Jianqin Shan; Michael Keating; Emil J Freireich
Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia.
Blood 2010;116(22):4422-9.
2010: William G Wierda; J E Castro; R Aguillon; D Sampath; A Jalayer; John McMannis; C E Prussak; Michael Keating; Thomas Kipps
A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154.
Leukemia 2010;24(11):1893-900.
2010: Aref Al-Kali; Varsha Gandhi; Mohamad Ayoubi; Michael Keating; Farhad Ravandi
Forodesine: review of preclinical and clinical data.
Future oncology (London, England) 2010;6(8):1211-7.
2010: Dushyant Verma; Andrew Lamb; Stefan Faderl; Susan O'Brien; Sherry Pierce; Khanh Vu; Emil Freireich; Michael Keating; Jorge Cortes; Farhad Ravandi
Late relapses in acute myeloid leukemia: analysis of characteristics and outcome.
Leukemia & lymphoma 2010;51(5):778-82.
2010: Aref Al-Kali; Michael Keating; William Wierda; Susan O'Brien
Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL).
Journal of blood medicine 2010;1():115-22.
2010: Ping Li; David Harris; Zhiming Liu; Jie Liu; Michael Keating; Zeev Estrov
Stat3 activates the receptor tyrosine kinase like orphan receptor-1 gene in chronic lymphocytic leukemia cells.
PloS one 2010;5(7):e11859.
2009: F P S Santos; Stefan Faderl; Guillermo Garcia-Manero; Charles Koller; Miloslav Beran; Susan O'Brien; Sherry Pierce; Emil J Freireich; Xuelin Huang; Gautam Borthakur; Carlos E Bueso-Ramos; Marcos De Lima; Michael Keating; Jorge Cortes; Andrew Lamb; Farhad Ravandi
Adult acute erythroleukemia: an analysis of 91 patients treated at a single institution.
Leukemia 2009;23(12):2275-80.
2009: Farhad Ravandi; Ahmed Aribi; Susan O'Brien; Stefan Faderl; Dan Jones; Alessandra Ferrajoli; Xuelin Huang; Sergernne York; Sherry Pierce; William G Wierda; Dimitrios Kontoyiannis; Srdan Verstovsek; Barbara Pro; Luis Fayad; Michael Keating; Andrew Lamb
Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(32):5425-30.
2009: Deborah A Thomas; Farhad Ravandi; Michael Keating; Hagop M Kantarjian
Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy.
Leukemia & lymphoma 2009;50 Suppl 1():27-31.
2009: Nitin Jain; William G Wierda; Alessandra Ferrajoli; Franklin Wong; Susan Lerner; Michael Keating; Susan O'Brien
A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia.
Cancer 2009;115(19):4533-9.
2009: Jan A Burger; Susan O'Brien; Xuemei Wang; Stefan Faderl; Alessandra Ferrajoli; Kim-Anh Do; Guillermo Garcia-Manero; Jorge Cortes; Deborah Thomas; Charles Koller; Jan Burger; Susan Lerner; Andrew Lamb; Michael Keating
Characteristics associated with important clinical end points in patients with chronic lymphocytic leukemia at initial treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(10):1637-43.
2009: Patricia Ault; Jorge Cortes; Alice Lynn; Michael Keating; Srdan Verstovsek
Pregnancy in a patient with hypereosinophilic syndrome.
Leukemia research 2009;33(1):186-7.
2008: Kedar V Inamdar; Susan O'Brien; Subrata Sen; Michael Keating; Martin H Nguyen; Xuemei Wang; Michael Fernandez; Vilmos A Thomazy; L Jeffrey Medeiros; Carlos E Bueso-Ramos
Aurora-A kinase nuclear expression in chronic lymphocytic leukemia.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(12):1428-35.
2008: Andrew Lamb; Susan O'Brien; Jorge Cortes; William G Wierda; Stefan Faderl; Guillermo Garcia-Manero; Jean-Pierre J Issa; Elihu Estey; Michael Keating; Emil J Freireich
Therapeutic advances in leukemia and myelodysplastic syndrome over the past 40 years.
Cancer 2008;113(7 Suppl):1933-52.
2007: Gautam Borthakur; Edward Lin; Stefan Faderl; Alessandra Ferrajoli; William G Wierda; Francis Giles; Mary L Browning; Andrew Lamb; Michael Keating; Susan O'Brien
Low serum albumin level is associated with cytomegalovirus reactivation in patients with chronic lymphoproliferative diseases treated with alemtuzumab (Campath-1H)-based therapies.
Cancer 2007;110(11):2478-83.
2007: Ehab Atallah; Jorge Cortes; Susan O'Brien; Sherry Pierce; Mary Beth Rios; Elihu Estey; Maurie Markman; Michael Keating; Emil J Freireich; Andrew Lamb
Establishment of baseline toxicity expectations with standard frontline chemotherapy in acute myelogenous leukemia.
Blood 2007;110(10):3547-51.
2007: Ahmed Aribi; Yang Huh; Michael Keating; Susan O'Brien; Alessandra Ferrajoli; Stefan Faderl; William G Wierda; Andrew Lamb; Farhad Ravandi
T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years.
Leukemia research 2007;31(7):939-45.
2007: William G Wierda; Susan O'Brien; Xuemei Wang; Stefan Faderl; Alessandra Ferrajoli; Kim-Anh Do; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Charles Koller; Miloslav Beran; Francis Giles; Farhad Ravandi; Susan Lerner; Andrew Lamb; Michael Keating
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia.
Blood 2007;109(11):4679-85.
2007: Farhad Ravandi; Iman Jilani; Elihu Estey; Andrew Lamb; A Dey; C Aguilar; C Jitkaroon; Francis Giles; Susan O'Brien; Michael Keating; Maher Albitar
Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML).
Leukemia research 2007;31(6):791-7.
2006: Charles Koller; B Nebiyou Bekele; Xian Zhou; Charles Park; Zeev Estrov; Susan O'Brien; Michael Keating; Iman Jilani; Francis Giles; Hagop M Kantarjian; Maher Albitar
Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukemia.
Blood 2006;108(3):1001-6.
2006: Stacey Ruiz; Yelena Krupnik; Michael Keating; Joya Chandra; Michael Palladino; David J McConkey
The proteasome inhibitor NPI-0052 is a more effective inducer of apoptosis than bortezomib in lymphocytes from patients with chronic lymphocytic leukemia.
Molecular cancer therapeutics 2006;5(7):1836-43.
2006: Apostolia-Maria Tsimberidou; Maribel Tirado-Gomez; Michael Andreeff; Susan O'Brien; Andrew Lamb; Michael Keating; Gabriel Lopez-Berestein; Elihu Estey
Single-agent liposomal all-trans retinoic acid can cure some patients with untreated acute promyelocytic leukemia: an update of The University of Texas M. D. Anderson Cancer Center Series.
Leukemia & lymphoma 2006;47(6):1062-8.
2006: Patricia Ault; Andrew Lamb; Susan O'Brien; Stefan Faderl; Miloslav Beran; Mary Beth Rios; Charles Koller; Francis Giles; Michael Keating; Moshe Talpaz; Jorge Cortes
Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1204-8.
2006: Andrew Lamb; Miloslav Beran; Jorge Cortes; Susan O'Brien; Francis Giles; Sherry Pierce; Jianqin Shan; William Plunkett; Michael Keating; Elihu Estey
Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome.
Cancer 2006;106(5):1099-109.
2006: William G Wierda; Susan O'Brien; Stefan Faderl; Alessandra Ferrajoli; Xuemei Wang; Kim-Anh Do; Guillermo Garcia-Manero; Deborah Thomas; Jorge Cortes; Farhad Ravandi-Kashani; Francis Giles; Susan Lerner; Andrew Lamb; Michael Keating
A retrospective comparison of three sequential groups of patients with Recurrent/Refractory chronic lymphocytic leukemia treated with fludarabine-based regimens.
Cancer 2006;106(2):337-45.
2005: Stefan Faderl; Kim-Anh Do; Marcella M Johnson; Michael Keating; Susan O'Brien; Iman Jilani; Alessandra Ferrajoli; Farhad Ravandi-Kashani; Christine Aguilar; Amanda Dey; Deborah A Thomas; Francis Giles; Hagop M Kantarjian; Maher Albitar
Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia.
Blood 2005;106(13):4303-7.
2005: Stefan Faderl; Steven Coutré; John C Byrd; Claire Dearden; A Denes; Martin J S Dyer; S A Gregory; J G Gribben; Peter Hillmen; Michael Keating; S Rosen; P Venugopal; Kanti Rai
The evolving role of alemtuzumab in management of patients with CLL.
Leukemia 2005;19(12):2147-52.
2005: Farhad Ravandi; Susan O'Brien; Dan Jones; Susan Lerner; Stefan Faderl; Alessandra Ferrajoli; William G Wierda; Guillermo Garcia-Manero; Deborah Thomas; Charles Koller; Srdan Verstovsek; Francis Giles; Jorge Cortes; Marco Herling; Andrew Lamb; Michael Keating
T-cell prolymphocytic leukemia: a single-institution experience.
Clinical lymphoma & myeloma 2005;6(3):234-9.
2005: Farhad Ravandi; Andrew Lamb; Dan Jones; Claire Dearden; Michael Keating; Susan O'Brien
Mature T-cell leukemias.
Cancer 2005;104(9):1808-18.
2005: Francis Giles; Susan O'Brien; Jorge Cortes; Srdan Verstovsek; Carlos E Bueso-Ramos; Jianqin Shan; Sherry Pierce; Guillermo Garcia-Manero; Michael Keating; Andrew Lamb
Outcome of patients with acute myelogenous leukemia after second salvage therapy.
Cancer 2005;104(3):547-54.
2005: William G Wierda; Susan O'Brien; Sijin Wen; Stefan Faderl; Guillermo Garcia-Manero; Deborah Thomas; Kim-Anh Do; Jorge Cortes; Charles Koller; Miloslav Beran; Alessandra Ferrajoli; Francis Giles; Susan Lerner; Maher Albitar; Andrew Lamb; Michael Keating
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4070-8.
2005: Stefan Faderl; Varsha Gandhi; Susan O'Brien; Peter L Bonate; Jorge Cortes; Elihu Estey; Miloslav Beran; William G Wierda; Guillermo Garcia-Manero; Alessandra Ferrajoli; Zeev Estrov; Francis Giles; Min Du; Monica Kwari; Michael Keating; William Plunkett; Andrew Lamb
Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias.
Blood 2005;105(3):940-7.
2004: Andrew Lamb; Deborah Thomas; Susan O'Brien; Jorge Cortes; Francis Giles; Sima Jeha; Carlos E Bueso-Ramos; Sherry Pierce; Jianqin Shan; Charles Koller; Miloslav Beran; Michael Keating; Emil J Freireich
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Cancer 2004;101(12):2788-801.
2004: Anna Rogers; Youngson Joe; Taghi Manshouri; Amanda Dey; Iman Jilani; Francis Giles; Elihu Estey; Emil J Freireich; Michael Keating; Andrew Lamb; Maher Albitar
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia.
Blood 2004;103(7):2799-801.
2004: Michael Keating; Steven Coutré; Kanti Rai; Anders Osterborg; Stefan Faderl; Ben Kennedy; Tom Kipps; Gerald P Bodey; John C Byrd; Steven Rosen; Claire Dearden; Martin J S Dyer; Peter Hillmen
Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia.
Clinical lymphoma 2004;4(4):220-7.
2004: Andrew Lamb; Susan O'Brien; Jorge Cortes; Francis Giles; Jianqin Shan; Mary Beth Rios; Stefan Faderl; Srdan Verstovsek; Guillermo Garcia-Manero; William G Wierda; Steven M Kornblau; Alessandra Ferrajoli; Michael Keating; Moshe Talpaz
Survival advantage with imatinib mesylate therapy in chronic-phase chronic myelogenous ;eukemia (CML-CP) after IFN-alpha failure and in late CML-CP, comparison with historical controls.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):68-75.
2003: Hagop M Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Mary Beth Rios; Jianqin Shan; Stefan Faderl; Guillermo Garcia-Manero; Alessandra Ferrajoli; Srdan Verstovsek; William G Wierda; Michael Keating; Moshe Talpaz
Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
Cancer 2003;98(12):2636-42.
2003: Iman Jilani; Susan O'Brien; Taghi Manshuri; Deborah A Thomas; Vilmos A Thomazy; Maha Imam; Sana Naeem; Srdan Verstovsek; Andrew Lamb; Francis Giles; Michael Keating; Maher Albitar
Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia.
Blood 2003;102(10):3514-20.
2003: Jessica C Pahler; Stacey Ruiz; Irina Niemer; Leslie R Calvert; Michael Andreeff; Michael Keating; Stefan Faderl; David J McConkey
Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(12):4570-7.
2003: Maha Ahmed; Francis Giles; Youngson Joe; Donna M Weber; Iman Jilani; Taghi Manshouri; Sergio Giralt; Marcos De Lima; Michael Keating; Maher Albitar
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma.
European journal of haematology 2003;71(3):174-8.
2003: Hagop M Kantarjian; Susan O'Brien; Jorge Cortes; Francis Giles; Stefan Faderl; Jean-Pierre J Issa; Guillermo Garcia-Manero; Mary Beth Rios; Jianqin Shan; Michael Andreeff; Michael Keating; Moshe Talpaz
Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemia.
Cancer 2003;98(3):522-8.
2003: Andrew Lamb; Susan O'Brien; Jorge Cortes; Francis Giles; Deborah Thomas; Steven M Kornblau; Jianquin Shan; Mary Beth Rios; Michael Keating; Emil J Freireich; Moshe Talpaz
Sudden onset of the blastic phase of chronic myelogenous leukemia: patterns and implications.
Cancer 2003;98(1):81-5.
2003: Srdan Verstovsek; Taghi Manshouri; Franklin O Smith; Francis Giles; Jorge Cortes; Elihu Estey; Andrew Lamb; Michael Keating; Sima Jeha; Maher Albitar
Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia.
Cancer 2003;97(9):2212-7.
2003: Ellen Schlette; L Jeffrey Medeiros; Michael Keating; Raymond Lai
CD79b expression in chronic lymphocytic leukemia. Association with trisomy 12 and atypical immunophenotype.
Archives of pathology & laboratory medicine 2003;127(5):561-6.
2003: Hagop M Kantarjian; Varsha Gandhi; Peter Kozuch; Stefan Faderl; Francis Giles; Jorge Cortes; Susan O'Brien; Nuhad Ibrahim; Fadlo R Khuri; Min Du; Mary Beth Rios; Sima Jeha; Peter McLaughlin; William Plunkett; Michael Keating
Phase I clinical and pharmacology study of clofarabine in patients with solid and hematologic cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(6):1167-73.
2003: Apostolia-Maria Tsimberidou; Elihu Estey; Jorge Cortes; Deborah Thomas; Stefan Faderl; Srdan Verstovsek; Guillermo Garcia-Manero; Michael Keating; Maher Albitar; Susan O'Brien; Andrew Lamb; Francis Giles
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes.
Cancer 2003;97(6):1481-7.
2003: Srdan Verstovsek; Andrew Lamb; Taghi Manshouri; Jorge Cortes; Stefan Faderl; Francis Giles; Michael Keating; Maher Albitar
Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia.
Cancer 2003;97(5):1248-52.
2003: Jorge Cortes; Andrew Lamb; Maher Albitar; Deborah Thomas; Stefan Faderl; Charles Koller; Guillermo Garcia-Manero; Francis Giles; Michael Andreeff; Susan O'Brien; Michael Keating; Elihu Estey
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.
Cancer 2003;97(5):1234-41.
2003: William G Wierda; Marcella M Johnson; Kim-Anh Do; Taghi Manshouri; Amanda Dey; Susan O'Brien; Francis Giles; Andrew Lamb; Deborah Thomas; Stefan Faderl; Susan Lerner; Michael Keating; Maher Albitar
Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia.
British journal of haematology 2003;120(3):452-6.
2003: Iman Jilani; Elihu Estey; T Manshuri; M Caligiuri; Michael Keating; Francis Giles; Deborah Thomas; Andrew Lamb; Maher Albitar
Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA.
Leukemia 2003;17(1):114-9.
2003: Raymond Lai; George Z Rassidakis; L Jeffrey Medeiros; Vasiliki Leventaki; Michael Keating; Timothy J McDonnell
Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours.
The Journal of pathology 2003;199(1):84-9.
2002: Iman Jilani; Elihu Estey; Yang Huh; Youngson Joe; Taghi Manshouri; Marwan Yared; Francis Giles; Andrew Lamb; Jorge Cortes; Deborah Thomas; Michael Keating; Emil J Freireich; Maher Albitar
Differences in CD33 intensity between various myeloid neoplasms.
American journal of clinical pathology 2002;118(4):560-6.
2002: Raymond Lai; Susan O'Brien; Taghi Maushouri; Anna Rogers; Andrew Lamb; Michael Keating; Maher Albitar
Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
Cancer 2002;95(5):1071-5.
2002: Apostolia-Maria Tsimberidou; Deborah Thomas; Susan O'Brien; Michael Andreeff; Razelle Kurzrock; Michael Keating; Maher Albitar; Andrew Lamb; Francis Giles
Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies.
Cancer chemotherapy and pharmacology 2002;50(3):237-42.
2002: Raymond Lai; Timothy J McDonnell; Sean L O'Connor; L Jeffrey Medeiros; R Oudat; Michael Keating; M B Morgan; Tyler J Curiel; Richard J Ford
Establishment and characterization of a new mantle cell lymphoma cell line, Mino.
Leukemia research 2002;26(9):849-55.
2002: Hagop M Kantarjian; Moshe Talpaz; Susan O'Brien; Terry L Smith; Francis Giles; Stefan Faderl; Deborah A Thomas; Guillermo Garcia-Manero; Jean-Pierre J Issa; Michael Andreeff; Steven M Kornblau; Charles Koller; Miloslav Beran; Michael Keating; Mary Beth Rios; Jianqin Shan; Debra Resta; Renaud Capdeville; Kimberly Hayes; Maher Albitar; Emil J Freireich; Jorge E Cortes
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2177-87.
2002: Hagop M Kantarjian; Susan O'Brien; Jorge E Cortes; Terry L Smith; Mary Beth Rios; Jianqin Shan; Ying Yang; Francis Giles; Deborah A Thomas; Stefan Faderl; Guillermo Garcia-Manero; Sima Jeha; William G Wierda; Jean-Pierre J Issa; Steven M Kornblau; Michael Keating; Debra Resta; Renaud Capdeville; Moshe Talpaz
Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2167-76.
2002: Srdan Verstovsek; Elihu Estey; Taghi Manshouri; Francis Giles; Jorge Cortes; Miloslav Beran; Anna Rogers; Michael Keating; Andrew Lamb; Maher Albitar
Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome.
British journal of haematology 2002;118(1):151-6.
2002: Esteban C Nannini; Michael Keating; Peter Binstock; George Samonis; Dimitrios P Kontoyiannis
Successful treatment of refractory disseminated Mycobacterium avium complex infection with the addition of linezolid and mefloquine.
The Journal of infection 2002;44(3):201-3.
2002: Susan O'Brien; Moshe Talpaz; Jorge Cortes; Jianqin Shan; Francis Giles; Stefan Faderl; Deborah Thomas; Guillermo Garcia-Manero; Susie Mallard; Mary Beth; Charles Koller; Steven M Kornblau; Michael Andreeff; Anthony J Murgo; Michael Keating; Hagop M Kantarjian
Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemia.
Cancer 2002;94(7):2024-32.
2002: Raymond Lai; Elihu Estey; Yu Shen; Simona Despa; Andrew Lamb; Miloslav Beran; Taghi Maushouri; Robert C Quackenbuch; Michael Keating; Maher Albitar
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome.
Cancer 2002;94(1):14-7.
2001: Mihaela Onciu; Ellen Schlette; L Jeffrey Medeiros; Lynne V Abruzzo; Michael Keating; Raymond Lai
Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities.
American journal of clinical pathology 2001;116(6):886-92.
2001: Jorge Cortes; Susan O'Brien; J Loscertales; Andrew Lamb; Francis Giles; Deborah Thomas; Charles Koller; Michael Keating
Cyclosporin A for the treatment of cytopenia associated with chronic lymphocytic leukemia.
Cancer 2001;92(8):2016-22.
2001: Srdan Verstovsek; Andrew Lamb; Alvaro Aguayo; Taghi Manshouri; Emil J Freireich; Michael Keating; Elihu Estey; Maher Albitar
Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome.
British journal of haematology 2001;114(2):290-5.
2001: Srdan Verstovsek; Andrew Lamb; Elihu Estey; Alvaro Aguayo; Francis Giles; Taghi Manshouri; Charles Koller; Zeev Estrov; Emil J Freireich; Michael Keating; Maher Albitar
Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.
Leukemia 2001;15(8):1165-70.
2001: Srdan Verstovsek; Elihu Estey; Taghi Manshouri; Michael Keating; Andrew Lamb; Francis Giles; Maher Albitar
High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome.
Leukemia & lymphoma 2001;42(3):511-6.
2001: Jorge Cortes; Elihu Estey; Susan O'Brien; Francis Giles; Yu Shen; Charles Koller; Miloslav Beran; Deborah Thomas; Michael Keating; Andrew Lamb
High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia.
Cancer 2001;92(1):7-14.
2001: S Ibrahim; Michael Keating; Kim-Anh Do; Susan O'Brien; Yang O Huh; Iman Jilani; Susan Lerner; Hagop M Kantarjian; Maher Albitar
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
Blood 2001;98(1):181-6.
2001: Alvaro Aguayo; Taghi Manshouri; Susan O'Brien; Michael Keating; Miloslav Beran; Charles Koller; Andrew Lamb; Anna Rogers; Maher Albitar
Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL).
Leukemia research 2001;25(4):279-85.
2001: Susan M O'Brien; Hagop M Kantarjian; Jorge Cortes; Miloslav Beran; Charles Koller; Francis Giles; Susan Lerner; Michael Keating
Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(5):1414-20.
2001: Stefan Faderl; Christy Gidel; Hagop M Kantarjian; Taghi Manshouri; Michael Keating; Maher Albitar
Loss of heterozygosity on chromosome 5 in adults with acute lymphoblastic leukemia.
Leukemia research 2001;25(1):39-43.
2000: Michael Keating; Susan O'Brien
High-dose rituximab therapy in chronic lymphocytic leukemia.
Seminars in oncology 2000;27(6 Suppl 12):86-90.
2000: S Ibrahim; Elihu H Estey; Sherry Pierce; Armand B. Glassman; Michael Keating; Susan O'Brien; Hagop M Kantarjian; Maher Albitar
11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses.
American journal of clinical pathology 2000;114(5):793-7.
2000: Alvaro Aguayo; Andrew Lamb; Taghi Manshouri; Christy Gidel; Elihu Estey; Deborah Thomas; Charles Koller; Zeev Estrov; Susan O'Brien; Michael Keating; Emil J Freireich; Maher Albitar
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.
Blood 2000;96(6):2240-5.
2000: Alvaro Aguayo; Susan O'Brien; Michael Keating; Taghi Manshouri; Christy Gidel; Bart Barlogie; Miloslav Beran; Charles Koller; Andrew Lamb; Maher Albitar
Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia.
Blood 2000;96(2):768-70.
2000: Farhad Ravandi-Kashani; Susan O'Brien; Taghi Manshouri; Susan Lerner; S Sim; K Dodd; Andrew Lamb; Emil J Freireich; Michael Keating; Maher Albitar
Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia.
Leukemia research 2000;24(6):469-74.
2000: C Y Chung; Andrew Lamb; Mohammad A Haidar; P Starostik; Taghi Manshouri; Christy Gidel; Emil J Freireich; Michael Keating; Maher Albitar
Deletions in the 13q14 locus in adult lymphoblastic leukemia: rate of incidence and relevance.
Cancer 2000;88(6):1359-64.
2000: Mohammad A Haidar; Andrew Lamb; Taghi Manshouri; C Y Chang; Susan O'Brien; Emil J Freireich; Michael Keating; Maher Albitar
ATM gene deletion in patients with adult acute lymphoblastic leukemia.
Cancer 2000;88(5):1057-62.
2000: Jorge Cortes; Elihu Estey; Miloslav Beran; Susan O'Brien; Francis Giles; Charles Koller; Michael Keating; Andrew Lamb
Cyclophosphamide, ara-C and topotecan (CAT) for patients with refractory or relapsed acute leukemia.
Leukemia & lymphoma 2000;36(5-6):479-84.
2000: J Faber; Andrew Lamb; M W Roberts; Michael Keating; Emil J Freireich; Maher Albitar
Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.
Archives of pathology & laboratory medicine 2000;124(1):92-7.
1999: Charles Koller; Hagop M Kantarjian; Eric J Feldman; Susan O'Brien; Mary Beth Rios; Elihu Estey; Michael Keating
A phase I-II trial of escalating doses of mitoxantrone with fixed doses of cytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia.
Cancer 1999;86(11):2246-51.
1999: Chung-Wu Lin; Susan O'Brien; J Faber; Taghi Manshouri; Jorge Romaguera; Yang O Huh; Andrew Lamb; Michael Keating; Maher Albitar
De novo CD5+ Burkitt lymphoma/leukemia.
American journal of clinical pathology 1999;112(6):828-35.
1999: Alvaro Aguayo; Elihu Estey; Andrew Lamb; T Mansouri; Christy Gidel; Michael Keating; Francis Giles; Zeev Estrov; Bart Barlogie; Maher Albitar
Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia.
Blood 1999;94(11):3717-21.
1999: Alvaro Aguayo; Jorge Cortes; Deborah Thomas; Sherry Pierce; Michael Keating; Andrew Lamb
Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia.
Cancer 1999;86(7):1203-9.
1999: Elihu H Estey; Francis Giles; Andrew Lamb; Susan O'Brien; Jorge Cortes; Emil J Freireich; Gabriel Lopez-Berestein; Michael Keating
Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia.
Blood 1999;94(7):2230-5.
1999: Miloslav Beran; Elihu Estey; Susan O'Brien; Jorge Cortes; Charles Koller; Francis Giles; Steven M Kornblau; Michael Andreeff; Norbert Vey; S R Pierce; Kimberly Hayes; G C Wong; Michael Keating; Andrew Lamb
Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2819-30.
1999: Jorge Cortes; Luis Fayad; Susan O'Brien; Michael Keating; Andrew Lamb
Persistence of peripheral blood and bone marrow blasts during remission induction in adult acute lymphoblastic leukemia confers a poor prognosis depending on treatment intensity.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2491-7.
1999: P Starostik; Susan O'Brien; C Y Chung; Mohammad A Haidar; Taghi Manshouri; Andrew Lamb; Emil J Freireich; Michael Keating; Maher Albitar
The prognostic significance of 13q14 deletions in chronic lymphocytic leukemia.
Leukemia research 1999;23(9):795-801.
1999: Susan O'Brien; Andrew Lamb; Charles Koller; E Feldman; Miloslav Beran; Michael Andreeff; Sergio Giralt; B Cheson; Michael Keating; Emil J Freireich; Mary Beth Rios; Moshe Talpaz
Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemia.
Blood 1999;93(12):4149-53.
1999: R Weinkauff; Elihu H Estey; P Starostik; Kimberly Hayes; Yang O Huh; Cheryl Hirsch-Ginsberg; Michael Andreeff; Michael Keating; Hagop M Kantarjian; Emil J Freireich; Maher Albitar
Use of peripheral blood blasts vs bone marrow blasts for diagnosis of acute leukemia.
American journal of clinical pathology 1999;111(6):733-40.
1999: B S Dabaja; Stefan Faderl; Deborah Thomas; Jorge Cortes; Susan O'Brien; F Nasr; Sherry Pierce; Kimberly Hayes; Armand B. Glassman; Michael Keating; Hagop M Kantarjian
Deletions and losses in chromosomes 5 or 7 in adult acute lymphocytic leukemia: incidence, associations and implications.
Leukemia 1999;13(6):869-72.
1999: Norbert Vey; Michael Keating; Francis Giles; J Cortes; Miloslav Beran; Elihu Estey
Effect of complete remission on survival in patients with acute myelogenous leukemia receiving first salvage therapy.
Blood 1999;93(9):3149-50.
1999: Jorge Cortes; Susan O'Brien; Elihu Estey; Francis Giles; Michael Keating; Andrew Lamb
Phase I study of liposomal daunorubicin in patients with acute leukemia.
Investigational new drugs 1999;17(1):81-7.
1999: Maher Albitar; Taghi Manshouri; Andrew Lamb; Michael Keating; Zeev Estrov; J Faber; Emil J Freireich; Sherry Pierce; Elihu Estey
Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia.
Leukemia research 1999;23(1):63-9.
1998: Joya Chandra; I Niemer; J Gilbreath; Kay-Oliver Kliche; Michael Andreeff; Emil J Freireich; Michael Keating; David J McConkey
Proteasome inhibitors induce apoptosis in glucocorticoid-resistant chronic lymphocytic leukemic lymphocytes.
Blood 1998;92(11):4220-9.
1998: Miloslav Beran; Elihu Estey; Susan M O'Brien; Francis Giles; Charles Koller; Steven M Kornblau; Michael Keating; Hagop M Kantarjian
Results of topotecan single-agent therapy in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
Leukemia & lymphoma 1998;31(5-6):521-31.
1998: P Starostik; Taghi Manshouri; Susan O'Brien; Emil J Freireich; Andrew Lamb; Mohammad A Haidar; Susan Lerner; Michael Keating; Maher Albitar
Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.
Cancer research 1998;58(20):4552-7.
1998: Jorge Cortes; Moshe Talpaz; Susan O'Brien; Mary Beth Rios; Alejandro Majlis; Michael Keating; Emil J Freireich; Andrew Lamb
Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3279-85.
1998: Issa F Khouri; Michael Keating; Martin Körbling; Donna Przepiorka; Paolo Anderlini; Susan O'Brien; Sergio Giralt; Cindy Ippoliti; B von Wolff; James L Gajewski; Michele Donato; David F Claxton; Naoto T Ueno; Borje Andersson; Adrian Gee; Richard Champlin
Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2817-24.
1998: J Cortes; Andrew Lamb; Susan O'Brien; R Kurzrock; Michael Keating; Moshe Talpaz
GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemia.
Leukemia 1998;12(6):860-4.
1998: M DeLima; Maher Albitar; Susan O'Brien; Sherry Pierce; Andrew Lamb; M Andreeff; Luis Fayad; Michael Keating; Elihu Estey
Comparison of referring and tertiary cancer center physician's diagnoses in patients with leukemia.
The American journal of medicine 1998;104(3):246-51.
1998: Steven M Kornblau; Andrew Lamb; Susan O'Brien; Michael Andreeff; Charles Koller; Miloslav Beran; Michael Keating; Elihu Estey
CECA-cyclophosphamide, etoposide, carboplatin and cytosine arabinoside--a new salvage regimen for relapsed or refractory acute myelogenous leukemia.
Leukemia & lymphoma 1998;28(3-4):371-5.
1997: Marcos De Lima; S S Strom; Michael Keating; Andrew Lamb; Sherry Pierce; Susan O'Brien; Emil J Freireich; Elihu Estey
Implications of potential cure in acute myelogenous leukemia: development of subsequent cancer and return to work.
Blood 1997;90(12):4719-24.
1997: Miloslav Beran; Sima Jeha; Susan O'Brien; Elihu Estey; L Vitek; M G Zurlo; Mary Beth Rios; Michael Keating; Andrew Lamb
Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2377-84.
1997: Charles Koller; Hagop M Kantarjian; Deborah Thomas; Susan O'Brien; Mary Beth Rios; Steven M Kornblau; S Murphy; Michael Keating
The hyper-CVAD regimen improves outcome in relapsed acute lymphoblastic leukemia.
Leukemia 1997;11(12):2039-44.
1997: Joya Chandra; J Gilbreath; Emil J Freireich; Kay-Oliver Kliche; Michael Andreeff; Michael Keating; David J McConkey
Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes.
Blood 1997;90(9):3673-81.
1997: Elihu Estey; Peter F Thall; Miloslav Beran; Andrew Lamb; Sherry Pierce; Michael Keating
Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy.
Blood 1997;90(8):2969-77.
1997: Elihu Estey; Peter F Thall; Andrew Lamb; Sherry Pierce; Steven M Kornblau; Michael Keating
Association between increased body mass index and a diagnosis of acute promyelocytic leukemia in patients with acute myeloid leukemia.
Leukemia 1997;11(10):1661-4.
1997: A W Bseiso; Hagop M Kantarjian; Jie Qiang Guo; Jorge Cortes; Moshe Talpaz; Charles Koller; Maher Albitar; Michael Keating; Ralph B Arlinghaus
Analysis of the BCR-ABL protein in Philadelphia chromosome-positive adult acute lymphocytic leukemia.
Leukemia 1997;11(9):1583-7.
1997: J Cortes; Andrew Lamb; Susan O'Brien; Miloslav Beran; Elihu Estey; Michael Keating; Moshe Talpaz
A pilot study of all-trans retinoic acid in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Leukemia 1997;11(7):929-32.
1997: Sergio Giralt; Elihu Estey; Maher Albitar; Koen van Besien; Gabriela Rondón; Paolo Anderlini; Susan O'Brien; Issa Khouri; James L Gajewski; RC Mehra; David F Claxton; Borje Andersson; Miloslav Beran; Donna Przepiorka; Charles Koller; Steven M Kornblau; M Kørbling; Michael Keating; Andrew Lamb; Richard Champlin
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
Blood 1997;89(12):4531-6.
1997: J Cortes; Andrew Lamb; Moshe Talpaz; Susan O'Brien; Miloslav Beran; C Koller; Michael Keating
Treatment of chronic myelogenous leukemia with nucleoside analogs deoxycoformycin and fludarabine.
Leukemia 1997;11(6):788-91.
1997: Steven M Kornblau; Elihu Estey; Timothy Madden; Hai T Tran; Shourong Zhao; U Consoli; Virginia Snell; G Sanchez-Williams; Andrew Lamb; Michael Keating; Robert A Newman; Michael Andreeff
Phase I study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1796-802.
1997: Hagop M Kantarjian; Susan M O'Brien; Elihu Estey; Sergio Giralt; Miloslav Beran; Mary Beth Rios; Michael Keating; D de Vos; Moshe Talpaz
Decitabine studies in chronic and acute myelogenous leukemia.
Leukemia 1997;11 Suppl 1():S35-6.
1997: Elihu Estey; Peter F Thall; Sherry Pierce; Andrew Lamb; Michael Keating
Treatment of newly diagnosed acute promyelocytic leukemia without cytarabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):483-90.
1996: Michael Keating; B Cheson; J G Gribben; B Robertson; Lee M Nadler
Innovative strategies for the treatment of CLL.
Leukemia & lymphoma 1996;22 Suppl 2():53-64.
1996: Miloslav Beran; Andrew Lamb; Susan O'Brien; Charles Koller; M al-Bitar; S Arbuck; Sherry Pierce; M Moore; James L Abbruzzese; Michael Andreeff; Michael Keating; Elihu Estey
Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemia.
Blood 1996;88(7):2473-9.
1996: David J McConkey; Joya Chandra; S Wright; William Plunkett; Timothy J McDonnell; J C Reed; Michael Keating
Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX.
Journal of immunology (Baltimore, Md. : 1950) 1996;156(7):2624-30.
1996: Peter McLaughlin; F B Hagemeister; Jorge Romaguera; Andreas H Sarris; O Pate; Anas Younes; F Swan; Michael Keating; Fernando Cabanillas
Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1262-8.
1996: Andreas H Sarris; J Cortes; Andrew Lamb; Sherry Pierce; T Smith; Michael Keating; Charles Koller; Steven M Kornblau; Susan O'Brien; Michael Andreeff
Disseminated intravascular coagulation in adult acute lymphoblastic leukemia: frequent complications with fibrinogen levels less than 100 mg/dl.
Leukemia & lymphoma 1996;21(1-2):85-92.
1996: Susan O'Brien; Sima Jeha; Andrew Lamb; Pavel Pisa; G Jin; Michael Keating; Miloslav Beran
Engraftment of chronic prolymphocytic and T cell leukemia in SCID mice.
Leukemia 1996;10(2):338-44.
1996: N Pollicardo; Susan O'Brien; E H Estey; M al-Bitar; Sherry Pierce; Michael Keating; Hagop M Kantarjian
Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution.
Leukemia 1996;10(1):27-31.
1995: H Alejandro Preti; Y O Huh; Susan M O'Brien; Michael Andreeff; S T Pierce; Michael Keating; Hagop M Kantarjian
Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis.
Cancer 1995;76(9):1564-70.
1995: Susan O'Brien; Andrew Lamb; Michael Keating; Miloslav Beran; Charles Koller; LE Robertson; Jeane Hester; Mary Beth Rios; Michael Andreeff; Moshe Talpaz
Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase.
Blood 1995;86(9):3322-6.
1995: C F Verschraegen; Hagop M Kantarjian; Cheryl Hirsch-Ginsberg; Ming-Sheng Lee; Susan O'Brien; Mary Beth Rios; Sanford A Stass; Michael Keating; Moshe Talpaz
The breakpoint cluster region site in patients with Philadelphia chromosome-positive chronic myelogenous leukemia. Clinical, laboratory, and prognostic correlations.
Cancer 1995;76(6):992-7.
1995: P Marlton; Michael Keating; Andrew Lamb; Sherry Pierce; Susan O'Brien; E J Freireich; Elihu Estey
Cytogenetic and clinical correlates in AML patients with abnormalities of chromosome 16.
Leukemia 1995;9(6):965-71.
1995: Elihu H Estey; Hagop M Kantarjian; Susan O'Brien; Steven M Kornblau; Michael Andreeff; Miloslav Beran; Sherry Pierce; Michael Keating
High remission rate, short remission duration in patients with refractory anemia with excess blasts (RAEB) in transformation (RAEB-t) given acute myelogenous leukemia (AML)-type chemotherapy in combination with granulocyte-CSF (G-CSF).
Cytokines and molecular therapy 1995;1(1):21-8.
1995: Susan O'Brien; Andrew Lamb; A Ellis; Leonard A Zwelling; Elihu Estey; Michael Keating
Topotecan in chronic lymphocytic leukemia.
Cancer 1995;75(5):1104-8.
1995: Susan O'Brien; Auro Del Giglio; Michael Keating
Advances in the biology and treatment of B-cell chronic lymphocytic leukemia.
Blood 1995;85(2):307-18.
1995: J E Cortes; Andrew Lamb; Susan O'Brien; Michael Keating; Sherry Pierce; Emil J Freireich; Elihu Estey
Clinical and prognostic significance of trisomy 21 in adult patients with acute myelogenous leukemia and myelodysplastic syndromes.
Leukemia 1995;9(1):115-7.
1995: Meletios A Dimopoulos; Donna Weber; Kay Delasalle; Michael Keating; Raymond Alexanian
Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(1):49-52.
1994: Meletios A Dimopoulos; Andrew Lamb; Donna Weber; Susan O'Brien; Elihu Estey; Kay Delasalle; E Rose; Fernando Cabanillas; Michael Keating; Raymond Alexanian
Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2694-8.
1994: J Cortes; Susan O'Brien; Andrew Lamb; A Cork; Sanford A Stass; Emil J Freireich; Michael Keating; Sherry Pierce; Elihu Estey
Abnormalities in the long arm of chromosome 11 (11q) in patients with de novo and secondary acute myelogenous leukemias and myelodysplastic syndromes.
Leukemia 1994;8(12):2174-8.
1994: J E Cortes; Andrew Lamb; Susan O'Brien; LE Robertson; Charles Koller; C Hirsh-Ginsberg; Sanford A Stass; Michael Keating; Elihu Estey
All-trans retinoic acid followed by chemotherapy for salvage of refractory or relapsed acute promyelocytic leukemia.
Cancer 1994;73(12):2946-52.
1994: Peter McLaughlin; F B Hagemeister; F Swan; Fernando Cabanillas; O Pate; Jorge Romaguera; Maria A Rodriguez; J R Redman; Michael Keating
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):575-9.
1994: Meletios A Dimopoulos; Donna M Weber; Andrew Lamb; Michael Keating; Raymond Alexanian
2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):288-9.
1994: Susan O'Brien; Andrew Lamb; Elihu Estey; Charles Koller; B Robertson; Miloslav Beran; Michael Andreeff; Sherry Pierce; Michael Keating
Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy.
The New England journal of medicine 1994;330(5):319-22.
1994: Alejandro Preti; Hagop M Kantarjian; Elihu Estey; Y Huh; Michael Keating; Sherry Pierce; Cheryl Hirsch-Ginsberg; G Yee; Sanford A Stass
Characteristics and outcome of patients with acute lymphocytic leukemia and myeloperoxidase-positive blasts by electron microscopy.
Hematologic pathology 1994;8(4):155-67.
1993: Elihu H Estey; Andrew Lamb; Michael Keating
Idarubicin plus continuous-infusion high-dose cytarabine as treatment for patients with acute myelogenous leukemia or myelodysplastic syndrome.
Seminars in oncology 1993;20(6 Suppl 8):1-5.
1993: S Suki; Andrew Lamb; Varsha Gandhi; Elihu Estey; Susan O'Brien; Miloslav Beran; Mary Beth Rios; William Plunkett; Michael Keating
Fludarabine and cytosine arabinoside in the treatment of refractory or relapsed acute lymphocytic leukemia.
Cancer 1993;72(7):2155-60.
1993: Susan O'Brien; Andrew Lamb; Miloslav Beran; T Smith; Charles Koller; Elihu Estey; LE Robertson; Susan Lerner; Michael Keating
Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment.
Blood 1993;82(6):1695-700.
1993: Auro Del Giglio; Susan O'Brien; R J Ford; J Manning; H Saya; Michael Keating; D Johnston; D F Chamone; Albert Deisseroth
Proliferating cell nuclear antigen (PCNA) expression in chronic lymphocytic leukemia (CLL).
Leukemia & lymphoma 1993;10(4-5):265-71.
1993: P M Derderian; Hagop M Kantarjian; Moshe Talpaz; Susan O'Brien; A Cork; Elihu Estey; Sherry Pierce; Michael Keating
Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis.
The American journal of medicine 1993;94(1):69-74.
1992: E Anaissie; Dimitrios P Kontoyiannis; Andrew Lamb; Linda S Elting; LE Robertson; Michael Keating
Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone.
Annals of internal medicine 1992;117(6):466-9.
1992: Auro Del Giglio; Susan O'Brien; R Ford; H Saya; J Manning; Michael Keating; D Johnston; R Khetan; A el-Naggar; Albert Deisseroth
Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia.
Blood 1992;79(10):2717-20.
1992: Elihu Estey; Peter F Thall; Andrew Lamb; Susan O'Brien; Charles Koller; Miloslav Beran; Jordan U Gutterman; Albert Deisseroth; Michael Keating
Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-C + daunorubicin: comparison to patients treated without GM-CSF.
Blood 1992;79(9):2246-55.
1992: Elihu Estey; J M Trujillo; A Cork; Susan O'Brien; Miloslav Beran; Andrew Lamb; Michael Keating; Emil J Freireich; Sanford A Stass
AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.
Hematologic pathology 1992;6(1):43-8.
1992: A Kemena; Varsha Gandhi; Donna S Shewach; Michael Keating; William Plunkett
Inhibition of fludarabine metabolism by arabinosylcytosine during therapy.
Cancer chemotherapy and pharmacology 1992;31(3):193-9.
1991: A Kemena; M Fernandez; J Bauman; Michael Keating; William Plunkett
A sensitive fluorescence assay for quantitation of fludarabine and metabolites in biological fluids.
Clinica chimica acta; international journal of clinical chemistry 1991;200(2-3):95-106.
1991: Susan O'Brien; Andrew Lamb; Elihu Estey; Charles Koller; Miloslav Beran; K McCredie; Michael Keating
Mitoxantrone and high-dose etoposide for patients with relapsed or refractory acute leukemia.
Cancer 1991;68(4):691-4.
1991: Susan O'Brien; J A Benvenuto; Elihu Estey; Miloslav Beran; T B Felder; Michael Keating
Phase I clinical investigation of benzisoquinolinedione (amonafide) in adults with refractory or relapsed acute leukemia.
Cancer research 1991;51(3):935-8.
1990: William Plunkett; V Heinemann; Elihu Estey; Michael Keating
Pharmacologically directed design of leukemia therapy.
Haematology and blood transfusion 1990;33():610-3.
1989: G A Gagnon; C C Childs; A LeMaistre; Michael Keating; A Cork; J M Trujillo; K Nellis; Emil J Freireich; Sanford A Stass
Molecular heterogeneity in acute leukemia lineage switch.
Blood 1989;74(6):2088-95.
1989: Susan O'Brien; Hagop M Kantarjian; Michael Keating; G Gagnon; A Cork; J Trujillo; K B McCredie
Association of granulocytosis with poor prognosis in patients with acute myelogenous leukemia and translocation of chromosomes 8 and 21.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):1081-6.
1989: Saroj Vadhan-Raj; Walter N Hittelman; H E Broxmeyer; Michael Keating; D Urdal; Jordan U Gutterman
In vivo biologic activities of recombinant human granulocyte-macrophage colony-stimulating factor.
Annals of the New York Academy of Sciences 1989;554():231-40.
1988: A R Zander; Michael Keating; K Dicke; D Dixon; Sherry Pierce; Sundar Jagannath; L Peters; L Horwitz; K Cockerill; G Spitzer
A comparison of marrow transplantation with chemotherapy for adults with acute leukemia of poor prognosis in first complete remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(10):1548-57.
1988: Saroj Vadhan-Raj; S Buescher; A LeMaistre; Michael Keating; R Walters; C Ventura; Walter N Hittelman; H E Broxmeyer; Jordan U Gutterman
Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor.
Blood 1988;72(1):134-41.
1988: R Amato; Andrew Lamb; R Walters; Michael Keating
Rebound peripheral blastosis with subsequent remission during remission induction in a patient with acute promyelocytic leukemia.
Cancer 1988;61(4):650-3.
1987: Saroj Vadhan-Raj; Michael Keating; A LeMaistre; Walter N Hittelman; K McCredie; J M Trujillo; H E Broxmeyer; C Henney; Jordan U Gutterman
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
The New England journal of medicine 1987;317(25):1545-52.
1987: L Danhauser; William Plunkett; J Liliemark; Varsha Gandhi; S Iacoboni; Michael Keating
Comparison between the plasma and intracellular pharmacology of 1-beta-D-arabinofuranosylcytosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine 5'-monophosphate in patients with relapsed leukemia.
Leukemia 1987;1(9):638-43.
1987: Elihu Estey; William Plunkett; D Dixon; Michael Keating; K McCredie; Emil J Freireich
Variables predicting response to high dose cytosine arabinoside therapy in patients with refractory acute leukemia.
Leukemia 1987;1(8):580-3.
1987: A R Zander; S Culbert; Sundar Jagannath; G Spitzer; Michael Keating; N Larry; K Cockerill; J Hester; L Horwitz; L Vellekoop
High dose cyclophosphamide, BCNU, and VP-16 (CBV) as a conditioning regimen for allogeneic bone marrow transplantation for patients with acute leukemia.
Cancer 1987;59(6):1083-6.
1987: Moshe Talpaz; Andrew Lamb; K McCredie; J Trujillo; Michael Keating; Jordan U Gutterman
Therapy of chronic myelogenous leukemia.
Cancer 1987;59(3 Suppl):664-7.
1987: K B McCredie; Moshe Talpaz; H Kantarjian; M Rosenblum; Michael Keating; Jordan U Gutterman
Biologic agents for the management of hematological disorders: chronic myeloid leukemia.
Haematology and blood transfusion 1987;31():120-2.
1987: Miloslav Beran; B Andersson; Andrew Lamb; Michael Keating; A Rios; K B McCredie; Emil J Freireich; Jordan U Gutterman
Hematologic response of four patients with smoldering acute myelogenous leukemia to partially pure gamma interferon.
Leukemia 1987;1(1):52-7.
1986: Moshe Talpaz; K McCredie; Andrew Lamb; J Trujillo; Michael Keating; Jordan U Gutterman
Chronic myelogenous leukaemia: haematological remissions with alpha interferon.
British journal of haematology 1986;64(1):87-95.
1985: A R Zander; K A Dicke; Michael Keating; L Vellekoop; S Culbert; G Spitzer; M Kanojia; Sundar Jagannath; S Schell; J Hester
Allogeneic bone marrow transplantation for acute leukemia refractory to induction chemotherapy.
Cancer 1985;56(6):1374-9.